BC Week In Review | Jun 25, 2012
Company News

Prolias Technologies, Cornell University deal

The university granted Prolias Technologies exclusive, worldwide rights to IP related to microRNA diagnostics developed at the Weill Cornell Medical College . The IP includes a miRNA panel to differentiate malignant and benign indeterminate thyroid nodules....
Items per page:
1 - 1 of 1